Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
12.43
+0.79 (6.79%)
At close: Aug 7, 2026, 4:00 PM EDT
12.43
0.00 (-0.04%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Trinity Biotech Revenue
In the year 2025, Trinity Biotech had annual revenue of $43.79M, down -28.87%. Trinity Biotech had revenue of $11.07M in the quarter ending December 31, 2025.
Revenue (ttm)
$43.79M
Revenue Growth
-28.87%
P/S Ratio
0.19
Revenue / Employee
$152,561
Employees
287
Market Cap
8.39M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 43.79M | -17.77M | -28.87% |
| Dec 31, 2024 | 61.56M | 4.72M | 8.31% |
| Dec 31, 2023 | 56.83M | -5.69M | -9.10% |
| Dec 31, 2022 | 62.52M | -18.63M | -22.96% |
| Dec 31, 2021 | 81.15M | -20.83M | -20.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Picard Medical | 5.47M |
| IceCure Medical | 3.57M |
| VolitionRx | 2.47M |
| Sintx Technologies | 1.03M |
| Co-Diagnostics | 718.17K |
| Nexalin Technology | 275.58K |
| Phaos Technology Holdings (Cayman) Limited | 147.64K |
| HeartSciences | 4.32K |
TRIB News
- 16 days ago - Trinity Biotech trading halted, news pending - TheFly
- 18 days ago - Trinity Biotech announces strategic collaboration agreement with Latch Medical - TheFly
- 18 days ago - Trinity Biotech announces plan to implement ADS ratio change - TheFly
- 18 days ago - Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology - GlobeNewsWire
- 18 days ago - Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change - GlobeNewsWire
- 5 weeks ago - New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring - GlobeNewsWire
- 5 weeks ago - Trinity Biotech's Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling - GlobeNewsWire
- 5 weeks ago - Trinity Biotech terminates standby equity purchase agreement with Yorkville - TheFly